variable | Univariate OR (95% CI) | P-value | Mutivariate OR (95% CI) | P-value |
---|---|---|---|---|
Nosocomial versus HCA | Â | Â | Â | Â |
  ≤ 1 | 6.160 (2.668–14.224) | 0.000 | 5.665 (2.277–14.092) | 0.000 |
 2–10 | 7.040 (2.203–22.497) | 0.001 | 5.332 (1.506–18.870) | 0.009 |
 11–18 | 24.640 (2.894–209.815) | 0.003 | 18.772 (2.09–168.583) | 0.009 |
 19–59 | 1.384 (0.766–2.502) | 0.282 | 1.308 (0.699–2.445) | 0.401 |
 Diabetes mellitus | 0.037 (0.187–0.948) | 0.037 | 0.609 (0.249–1.487) | 0.276 |
 Hematological malignancy | 2.425 (1.287–4.570) | 0.006 | 1.882 (0.686–5.166) | 0.220 |
 Brain tumor | 3.052 (1.124–8.284) | 0.029 | 3.411 (1.139–10.215) | 0.028 |
 Cerebral vascular disease | 0.525 (0.273–1.009) | 0.053 | 0.841 (0.395–1.792) | 0.654 |
 Hypertension | 0.528 (0.294–0.949) | 0.033 | 1.189 (0.592–2.391) | 0.626 |
 Immunosuppression | 1.653 (0.941–2.904) | 0.081 | 0.912 (0.37–2.249) | 0.912 |
Nosocomial versus CA | Â | Â | Â | Â |
  ≤ 1 | 5.040 (1.660–15.299) | 0.004 | 4.456 (1.405–14.135) | 0.011 |
 2–10 | 12.000 (1.436–100.278) | 0.022 | 4.727 (0.494–45.221) | 0.178 |
 11–18 | 4.800 (0.933–24.692) | 0.061 | 1.981 (0.327–12.001) | 0.457 |
 19–59 | 0.850 (0.427–1.693) | 0.644 | 0.671 (0.312–1.442) | 0.307 |
 Diabetes mellitus | 0.230 (0.097–0.544) | 0.001 | 0.342 (0.129–0.906) | 0.031 |
 Hematological malignancy | 9.475 (2.747–32.681) | 0.000 | 4.467 (0.933–21.395) | 0.061 |
 Brain tumor | 4.773 (1.016–22.427) | 0.048 | 7.865 (1.554–39.817) | 0.013 |
 Immunosuppression | 5.604 (2.197–14.291) | 0.000 | 2.762 (0.807–9.461) | 0.106 |
HCA versus CA | Â | Â | Â | Â |
 Diabetes mellitus | 0.546 (0.300–0.993) | 0.047 | 0.554 (0.288–1.067) | 0.077 |
 Hematological malignancy | 3.700 (1.080–12.674) | 0.037 | 2.62 (0.664–10.344) | 0.169 |
 Cerebral vascular disease | 2.414 (1.156–5.041) | 0.019 | 2.486 (1.154–5.356) | 0.02 |
 Hypertension | 1.848 (1.003–3.404) | 0.049 | 2.08 (1.065–4.061) | 0.032 |
 Immunosuppression | 3.227 (1.309–7.954) | 0.011 | 2.661 (0.971–7.297) | 0.057 |